logo
BSE Midcap index outperforms; L&T Finance, Muthoot, UPL hit 52-week highs

BSE Midcap index outperforms; L&T Finance, Muthoot, UPL hit 52-week highs

Shares of midcap companies were in focus on Monday, with the BSE Midcap index outperforming the broader market in intra-day trade, driven by a rally of over 2 per cent in stocks such as L&T Finance, UPL, Jindal Stainless, Supreme Industries, and Ashok Leyland.
As of 01:37 PM: BSE Midcap index, the top gainer among broader indices, was up 0.55 per cent, as compared to 0.38 per cent rise in the BSE Sensex and 0.09 per cent gain in the BSE Smallcap index.
In the past month, BSE Midcap indeed has gained 3.3 per cent, as against a marginal 0.2 per cent rise in the BSE Sensex. However, the BSE Smallcap index has rallied 5 per cent during the period.
Dalmia Bharat, Muthoot Finance, UPL, Vishal Mega Mart and L&T Finance from the BSE Midcap index have hit their respective 52-week highs in intra-day trade today.
Stocks driving the rally
Among the individual stocks, L&T Finance has surged 5 per cent to ₹212.75 after the non-banking finance company (NBFC) reported a steady performance in June 2025 quarter (Q1FY26) with visible recovery in rural portfolios.
Business growth remained a tad slower, excluding acquired portfolio. Collection efficiency remained steady in rural finance, though management commentary is awaited on future trend, ICICI Securities said in a note.
Shares of UPL hit a 52-week high of ₹712.75, soaring 4 per cent in intra-day trade. The stock price of pesticides & agrochemicals has rallied 12 per cent on a healthy business outlook.
Looking ahead, domestic growth of crop protection market in FY26 is expected to gain momentum, driven by favourable monsoon forecasts, stable commodity prices, and robust sowing activity.
On the export front, a recovery is projected in the second half of FY26, as international markets stabilise and inventory destocking by distribution channels nears completion. However, historically low realisations will continue to weigh on growth, preventing a return to the double-digit figures. This comes despite ongoing pricing pressures from oversupply in China, albeit less acute than last year. This trend is expected to persist, resulting in fewer inventory write-offs.
Moreover, improved volumes should bolster the sector's profitability. Operating margins are also on a slow path to recovery. Controlled debt and a gradual rebound in operating profitability will help sustain stable debt-protection metrics over the near to medium term, UPL said in its FY25 annual report.
Share price of Nippon Life India Asset Management (NAM India) was up 4 per cent to ₹871.1 in intra-day trade. In the past month, the stock has rallied 19 per cent. NAM India is a leading asset manager with a strong track record in India. The company provides a diverse range of investment products, including Mutual Funds, ETFs, Managed Accounts (including AIF and PMS), Offshore Business and GIFT City products, serving a wide base of investors.
Given the low level of Mutual Fund penetration in India (only 4 per cent of India's population invests), there exists a vast growth opportunity going forward. This will be further amplified as India continues down its path to become the third largest economy in the world, which will see a gradual increase in Per Capita Income for the population (currently at only $2,500), NAM India said.
Analysts at InCred Equities said they appreciate the overall healthy scheme-wise delivery by the industry, which, in turn, continues to attract equity asset under management (AUM).
The brokerage firm believes the following key catalysts will continue to aid the inflow momentum - improving capital market sentiment and rising purchasing power, especially of the younger demographic segment, and falling interest rates. Healthy equity fund inflows are aiding the yield movement, and analysts expect overall yields to remain healthy in the medium term.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hexaware Technologies Q2 Results: Profit jumps 38% YoY to Rs 380 crore but misses estimates
Hexaware Technologies Q2 Results: Profit jumps 38% YoY to Rs 380 crore but misses estimates

Time of India

time8 hours ago

  • Time of India

Hexaware Technologies Q2 Results: Profit jumps 38% YoY to Rs 380 crore but misses estimates

Carlyle-backed Hexaware Technologies reported a 38% on-year rise in June quarter net profit in rupee terms at Rs 380 crore. Profit rose 16% sequentially. Profit trailed expectations, largely due to a more than 20% increase in other expenses such as acquisition-related cost, and impairment of customer contract associated with an earlier acquisition. Hexaware issued a muted revenue guidance for the year ahead. The company follows a January to December financial year. Unlike its mid-tier peers, Hexaware's Q2 revenue was relatively subdued at Rs 3,260 crore, rising 11.1% on-year and 1.6% sequentially in constant currency terms, lagging Street estimates. In constant currency terms, revenue stood at $382.1 million, growing 1.3% sequentially and 7.5% from a year ago. During the quarter, revenue growth was impacted by decline in manufacturing and consumer segments, and flat growth in financial services. Live Events 'Our growth expectations for the year are a little bit lower now than it was in the beginning of Q2,' R. Srikrishna, CEO, Hexaware told ET. 'With lots of new promises of higher tariffs against multiple countries…that's on the negative side. On the positive side, some trade deals have been announced with some smaller countries and there could be a slew of them in the next few weeks,' he added. Shares of Hexaware fell sharply on the earnings announcement. They closed 10.7% lower at Rs 738.25 apiece, underperforming a 0.88% decline in the benchmark BSE Sensex. The Hexaware management said there is softness and cyclicality in the macro environment, and that all large consolidation deals are continuing. 'Small and mid-sized deals are progressing well. However, decision making is slowed. Consequently, lowered expectations for the rest of the year,' the company said. Geographically, Europe witnessed growth both on-year and sequentially, but Asia Pacific witnessed a decline from a year ago, and marginal growth from the March quarter. 'There will be one or two quarters which will have blips (in Asia Pacific) but long-term, in general, it will be positive,' said Srikrishna. 'In India, we made an acquisition to serve GCC (global capability centre) customers here. In the Middle East, we continue to have a strong pipeline and expect to convert in Q3 and grow revenues in Q4.' This month, Hexaware acquired Bengaluru-based SMC Squared for $120 million (about Rs 1,038 crore) in an all-cash deal, which is expected to add revenue growth in the coming two quarters. While adjusted margin improved to 18.1%, up from 17.1% in the March quarter, its full-year margin guidance stood at 17.1–17.4%. The company expects banking to continue to deliver better sequential growth despite a one-off degrowth in Q1 which will impact financial services for the full year. 'On manufacturing, customers are waiting for clarity on costs. Once that happens, it takes a few weeks to translate that into what it means for them,' Srikrishna said.

Stock market update: Nifty Pharma index advances 0.54%
Stock market update: Nifty Pharma index advances 0.54%

Economic Times

time8 hours ago

  • Economic Times

Stock market update: Nifty Pharma index advances 0.54%

NEW DELHI: The Nifty Pharma index closed on a positive note on Friday. ADVERTISEMENT Shares of Cipla Ltd.(up 3.0 per cent), Torrent Pharmaceuticals Ltd.(up 2.39 per cent), Dr. Reddy's Laboratories Ltd.(up 0.98 per cent), Aurobindo Pharma Ltd.(up 0.79 per cent) and J B Chemicals & Pharmaceuticals Ltd.(up 0.74 per cent) ended the day as top gainers in the pack. On the other hand, Natco Pharma Ltd.(down 3.15 per cent), Abbott India Ltd.(down 2.32 per cent), Ipca Laboratories Ltd.(down 2.07 per cent), Granules India Ltd.(down 1.59 per cent) and Biocon Ltd.(down 0.87 per cent) finished as the top losers of the day. The Nifty Pharma index closed 0.54 per cent up at 22662.7. Benchmark NSE Nifty50 index ended down 225.1 points at 24837.0, while the BSE Sensex stood down 721.08 points at 81463.09. Among the 50 stocks in the Nifty index, 7 ended in the green, while 43 closed in the red. ADVERTISEMENT Shares of Indian Energy Exchg, Vodafone Idea, Trident Ltd, YES Bank and RattanIndia Power were among the most traded shares on the NSE. Shares of Sharda Cropchem, Vimta Labs, Times Guaranty, Tatva Chintan Pharma Chem and Stallion India Fluor hit their fresh 52-week highs in today's trade, while Shalimar Paints, Stampede Cap, Shriram EPC(PP), Vipul Ltd and Raymond Realty hit their fresh 52-week lows. ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)

INR weakens further amid strong dollar and negative cues from local equities
INR weakens further amid strong dollar and negative cues from local equities

Business Standard

time8 hours ago

  • Business Standard

INR weakens further amid strong dollar and negative cues from local equities

The Indian rupee declined 16 paise to settle at 86.56 (provisional) against the US dollar on Friday, tracking negative domestic equity markets and surging global crude oil prices. Indian shares fell sharply, with uncertainty around U.S. trade deal, signs of slowing earnings growth and continued selling by foreign investors weighing on markets. The benchmark BSE Sensex tumbled 721.08 points, or 0.88 percent, to 81,463.09, extending losses from the previous session. The broader NSE Nifty index dropped 225.10 points, or 0.90 percent, to 24,837. Meanwhile, a strengthening American currency overseas and foreign fund outflows further weighed on the local unit. DXY, which tracks the greenbacks performance against a basket of six currencies, is up nearly half a percent at 97.55. At the interbank foreign exchange, the domestic unit opened at 86.59 and hit the lowest level of 86.63 against the greenback. The unit touched the intra-day peak of 86.47 before ending the session at 86.52 (provisional), registering a loss of 12 paise from its previous closing level. On the NSE, USDINR futures climbed 0.17% at 86.57.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store